OPEN END-TURBO-OPTIONSSCHEIN - AMGEN | Market Closed - BOERSE MUENCHEN 15:36:48 2024-06-25 EDT | ||
| 1.34 EUR | +3.08% |
|
| Current month | +9.24% | ||
| 1 month | +7.44% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 1.34 | +3.08% |
| 24-06-24 | 1.3 | +3.17% |
| 24-06-21 | 1.26 | +1.61% |
| 24-06-20 | 1.24 | +2.48% |
| 24-06-19 | 1.21 | 0.00% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 03:36 pm
More quotesStatic data
| Product type | Knock-Out sin Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | HSBC |
| WKN | TT0LRZ |
| ISIN | DE000TT0LRZ3 |
| Date issued | 2020-01-28 |
| Strike | 176.8 $ |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.61 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.42 € |
|---|---|
| Lowest since issue | 0.22 € |
| Spread | 0.03 € |
| Spread % | 2.21% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
319.3
USD
Average target price
316.4
USD
Spread / Average Target
-0.90%
- Stock Market
- Certificates
- Certificat
